pith. machine review for the scientific record. sign in

arxiv: 2604.24417 · v1 · submitted 2026-04-27 · ⚛️ physics.med-ph · physics.optics· physics.plasm-ph

Recognition: unknown

Potential pof laser-driven VHEEs towards FLASH radiotherapy: Monte Carlo dosimetric study of single-field pencil beam scanning of a brain tumor

Leonida A. Gizzi , Damiano Del Sarto , Federico Avella , Gabriele Bandini , Simona Piccinini , Daniele Panetta , Davide Terzani , Luca Labate
Authors on Pith no claims yet

Pith reviewed 2026-05-07 17:16 UTC · model grok-4.3

classification ⚛️ physics.med-ph physics.opticsphysics.plasm-ph
keywords laser wakefield accelerationvery high energy electronsFLASH radiotherapyMonte Carlo dosimetrypencil beam scanningbrain tumordose volume histogramsenergy spread
0
0 comments X

The pith

Laser-driven electron beams reach therapeutic doses for brain tumors via pencil beam scanning

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The paper examines whether very high energy electrons accelerated by lasers can treat deep-seated brain tumors in radiotherapy, with emphasis on the potential FLASH effect that may protect healthy tissue at ultra-high dose rates. It models a scanning procedure where multiple narrow pencil beams are overlapped to cover the entire tumor volume, accounting for the beams' natural energy spread and small size. Simulations indicate that suitable dose patterns result from this tessellation, supported by dose volume histograms, and a basic model of healthy tissue sparing is included. This matters because laser-based accelerators could offer compact alternatives to conventional machines if the modeled dose delivery holds up.

Core claim

Therapeutic doses are already at reach using pencil beams produced via laser wakefield acceleration. The entire tumor coverage is achieved by a scanning procedure; the dose pattern resulting from tessellation, i.e. the overlapping of adjacent beamlets, and the role of energy spread are thoroughly discussed. Dose volume histograms are presented and their quality is discussed. The impact of the FLASH effect is also considered, introducing a degree of healthy tissue sparing in the modelling.

What carries the argument

Monte Carlo simulation of dose deposition from scanned laser wakefield accelerated very high energy electron pencil beams, with analysis of beamlet tessellation and energy spread effects on tumor coverage

If this is right

  • Therapeutic dose levels are achievable with existing properties of laser-produced pencil beams.
  • Overlapping scanned beamlets produce full tumor coverage despite the beams' energy spread.
  • Energy spread influences but does not prevent acceptable dose patterns as shown in the histograms.
  • Incorporating healthy tissue sparing supports the feasibility of the FLASH effect in this setup.
  • Further laser and beam development can reach the ultra-high average dose rates needed for FLASH.

Where Pith is reading between the lines

These are editorial extensions of the paper, not claims the author makes directly.

  • Compact laser accelerators might reduce the size and cost of radiotherapy equipment compared to large conventional machines.
  • Real-world tests with actual laser beams on phantoms would be required to verify the simulated dose accuracy.
  • The scanning approach could extend to other deep tumor sites if beam parameters are adjusted accordingly.

Load-bearing premise

The Monte Carlo code accurately predicts real dose deposition for these laser beams with their energy spread and size, and the simple model of healthy tissue sparing correctly represents the actual FLASH effect.

What would settle it

An experiment measuring dose distributions in a brain tumor phantom with a real laser-driven electron beam where the observed dose volume histograms deviate substantially from the simulated results or where no healthy tissue sparing occurs at high dose rates.

Figures

Figures reproduced from arXiv: 2604.24417 by Damiano Del Sarto, Daniele Panetta, Davide Terzani, Federico Avella, Gabriele Bandini, Leonida A. Gizzi, Luca Labate, Simona Piccinini.

Figure 1
Figure 1. Figure 1: 3D dose pattern obtained in a recent experiment with laser-driven VHEE beams. The target volume was placed at the center of cylindrical phantom with 10cm diameter. Beam features were the same as those reported in48 . of a 10cm size cylindrical phantom. The results mentioned above, both theoretical and experimental, make a compelling case for the investigation of the dosimetric features of existing laser-dr… view at source ↗
Figure 2
Figure 2. Figure 2: left: Sketch of the simulated setup for beamlet dosimetry.right: Percentage Dose Depth curves for two different values of the low-energy cut, as resulting from Monte Carlo simulations. Results Single pencil beam dosimetry As a first step to approach the study of a scanning procedure to cover the tumor volume, we preliminarily investigated the dosimetric features of our beam at the position of the brain mod… view at source ↗
Figure 3
Figure 3. Figure 3: Left: Transverse dose distribution map, with isodose curves. Right: Transverse beamlet profile. Brain tumor scanning dosimetry Here we present the results of the simulated irradiation of a simplified deep seated brain tumor, whose coverage was carried out with a scanning technique using the pencil beam characterized above. The beamlets were sent to the patient along a common direction, which in the followi… view at source ↗
Figure 4
Figure 4. Figure 4: Ad hoc placed tumor volume (red sphere of ∼10 cc) in the reconstructed CT volume; projections and 3D view. Perspectives for laser-driven VHEE RT and open issues In this work, we have investigated via Monte Carlo simulations the potential of a typical laser-driven VHEE pencil beam for the irradiation of a deep brain tumor via a scanning procedure. Although no attempt has been made here to optimize the dose … view at source ↗
Figure 5
Figure 5. Figure 5: Dose deposition of the pencil beam scanning simulation. PTV and organs-at-risks segmentations are superimposed to the CT image view at source ↗
Figure 6
Figure 6. Figure 6: Dose Volume Histogram of the irradiated areas. which leads to a reduced PDD depth (in terms, for instance, of R80 or similar) is already well known, new figures need to be identified to evaluate the ability of a beam to treat deep seated tumors, as shown by this work, where a PTV beyond the "conventional" R80 depth was covered. In addition to all these considerations, it is clear that the exploitation of t… view at source ↗
read the original abstract

Radiotherapy with Very High Energy Electron (VHEE) beams is being extensively investigated for the treatment of deep-seated tumours, even in view of novel protocols based on the so-called FLASH effect. Laser WakeField Acceleration (LWFA) provides a compact and affordable accelerator technology for VHEE electron beams, featuring ultra-high instantaneous dose rates and holding the promise to provide Ultra-High (average) Dose Rates (UHDRs) needed to activate the FLASH effect, with major efforts ongoing worldwide to fulfill this promise. Therapeutic doses are already at reach, using pencil beams produced via LWFA. These beams typically exhibit significant energy spread, and small transverse size. These features are rather different from those of other beams considered so far in radiotherapy studies. In view of a rapid clinical translation of LWFA-VHEE beams it is therefore of paramount importance to assess the role of these properties in the dose delivery to the patient. Here we present a study carried out via start-to-end (PIC and Monte Carlo) simulations, of the main dosimetric features of a realistic laser-driven VHEE pencil beam targeted on a brain tumor. The entire tumor coverage is achieved by a scanning procedure; the dose pattern resulting from tessellation, i.e. the overlapping of adjacent beamlets, and the role of energy spread are thoroughly discussed. Dose Volume Histograms are presented, and their quality is discussed. The impact of the FLASH effect is also considered, introducing a degree of healthy tissue sparing in the modelling. Finally, the foreseen technological path toward the achievement of FLASH dose rates with LWFA-VHEE beams is briefly outlined.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit. Tearing a paper down is the easy half of reading it; the pith above is the substance, this is the friction.

Referee Report

2 major / 2 minor

Summary. The manuscript presents a start-to-end simulation study (PIC for LWFA beam generation followed by Monte Carlo transport) of single-field pencil-beam scanning with laser-driven VHEE beams for a brain tumor. It examines dose patterns arising from beamlet tessellation and overlapping, the influence of beam energy spread, dose-volume histograms, and the incorporation of a simple scaling factor to model healthy-tissue sparing under the FLASH effect. The central claim is that therapeutic doses are already reachable with realistic LWFA-VHEE parameters.

Significance. If the modeled dose distributions prove robust, the work provides a concrete dosimetric roadmap for compact LWFA accelerators in VHEE radiotherapy, highlighting how the distinctive beam properties (energy spread, small transverse size) affect tumor coverage and healthy-tissue exposure. The explicit treatment of tessellation and energy-spread effects supplies falsifiable predictions that can guide upcoming experiments.

major comments (2)
  1. [FLASH modeling discussion] The FLASH-effect modeling introduces healthy-tissue sparing as a simple scaling factor without reference to specific dose-rate thresholds, biological data, or sensitivity tests to the chosen factor value. This assumption directly supports the claims about FLASH impact yet remains unexamined in the results.
  2. [Results and dosimetric analysis] Statistical uncertainties on the Monte Carlo dose tallies are not reported, nor are sensitivity analyses performed on key inputs such as energy spread, pencil-beam size, or scanning step size. These omissions weaken the reliability of the reported dose patterns, DVHs, and feasibility conclusion.
minor comments (2)
  1. [Title] The title contains an apparent typographical error ('pof' instead of 'of').
  2. [Methods] Notation for beam parameters (e.g., energy spread, transverse size) could be defined more explicitly at first use to aid readers unfamiliar with LWFA beam characteristics.

Simulated Author's Rebuttal

2 responses · 0 unresolved

We thank the referee for the constructive comments and positive assessment of the significance of our Monte Carlo dosimetry study on laser-driven VHEE beams. We address each major comment point by point below, indicating the revisions we will implement.

read point-by-point responses

  1. Referee: [FLASH modeling discussion] The FLASH-effect modeling introduces healthy-tissue sparing as a simple scaling factor without reference to specific dose-rate thresholds, biological data, or sensitivity tests to the chosen factor value. This assumption directly supports the claims about FLASH impact yet remains unexamined in the results.

    Authors: We agree that the FLASH modeling in the original manuscript is preliminary and relies on a simplified scaling factor without sufficient supporting details. In the revised version, we will expand the relevant section to reference current literature on FLASH dose-rate thresholds and biological mechanisms, specify the assumed ultra-high dose-rate regime consistent with LWFA-VHEE parameters, and include a sensitivity analysis on the scaling factor value to quantify its effect on DVHs and healthy-tissue sparing estimates. These changes will provide a more thorough examination of the modeling assumptions. revision: yes

  2. Referee: [Results and dosimetric analysis] Statistical uncertainties on the Monte Carlo dose tallies are not reported, nor are sensitivity analyses performed on key inputs such as energy spread, pencil-beam size, or scanning step size. These omissions weaken the reliability of the reported dose patterns, DVHs, and feasibility conclusion.

    Authors: We acknowledge that statistical uncertainties were not explicitly reported and that sensitivity analyses on key parameters were not included, which limits the robustness assessment. In the revised manuscript, we will add statistical error estimates to all dose distributions, DVHs, and derived metrics by increasing the simulated particle histories and applying standard Monte Carlo uncertainty quantification. We will also perform and present sensitivity studies varying the energy spread, pencil-beam size, and scanning step size over realistic LWFA-VHEE ranges to demonstrate the stability of the tessellation patterns, tumor coverage, and overall feasibility conclusions. revision: yes

Circularity Check

0 steps flagged

No significant circularity in forward simulation study

full rationale

The paper is a start-to-end numerical study that generates LWFA beams via PIC simulation and then transports them through a patient model using Monte Carlo codes to compute dose distributions, DVHs, and a simple FLASH sparing factor. All reported dose metrics, tumor coverage via beamlet scanning, and energy-spread effects are direct numerical outputs of these standard codes rather than results of any analytical derivation, parameter fitting, or self-referential definition. No equations are presented that reduce predictions to inputs by construction, no uniqueness theorems are invoked, and no load-bearing claims rest on self-citations. The work therefore contains no circular steps of the enumerated kinds and is self-contained within its stated simulation assumptions.

Axiom & Free-Parameter Ledger

0 free parameters · 2 axioms · 0 invented entities

Only the abstract was available for review; detailed simulation parameters and validation steps could not be examined. The work relies on standard radiation-transport physics rather than new postulates.

axioms (2)
  • domain assumption Standard Monte Carlo radiation transport accurately models electron dose deposition in tissue for the given beam parameters
    Invoked to generate all reported dose distributions and DVHs.
  • ad hoc to paper Healthy tissue sparing can be introduced as a simple scaling factor to represent the FLASH effect
    Explicitly added in the modeling section of the abstract.

pith-pipeline@v0.9.0 · 5640 in / 1169 out tokens · 69219 ms · 2026-05-07T17:16:20.079824+00:00 · methodology

discussion (0)

Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.

Reference graph

Works this paper leans on

68 extracted references · 54 canonical work pages

  1. [1]

    Heal.12, e1945–e1953 (2024)

    Zhu, H.et al.Global radiotherapy demands and corresponding radiotherapy-professional workforce requirements in 2022 and predicted to 2050: a population-based study.The Lancet Glob. Heal.12, e1945–e1953 (2024)

    2022

  2. [2]

    Oncol.17, 196, DOI: 10.1186/ s13014-022-02171-7 (2022)

    Chen, H.et al.Radiotherapy modulates tumor cell fate decisions: a review.Radiat. Oncol.17, 196, DOI: 10.1186/ s13014-022-02171-7 (2022)

    2022

  3. [3]

    Favaudon, V .et al.Ultrahigh dose-rate flash irradiation increases the differential response between normal and tumor tissue in mice.Sci. Transl. Medicine6, 245ra93–245ra93, DOI: 10.1126/scitranslmed.3008973 (2014). https://www.science.org/ doi/pdf/10.1126/scitranslmed.3008973

    work page doi:10.1126/scitranslmed.3008973 2014

  4. [4]

    Panaino, C. M. V .et al.Very high-energy electron therapy toward clinical implementation.Cancers17, DOI: 10.3390/ cancers17020181 (2025)

    2025

  5. [5]

    V ozenin, M.-C., Hendry, J. H. & Limoli, C. Biological benefits of ultra-high dose rate flash radiotherapy: sleeping beauty awoken.Clin. oncology31, 407–415 (2019)

    2019

  6. [6]

    V ozenin, M.-C.et al.Flash: New intersection of physics, chemistry, biology, and cancer medicine.Rev. Mod. Phys.96, 035002, DOI: 10.1103/RevModPhys.96.035002 (2024)

    work page doi:10.1103/revmodphys.96.035002 2024

  7. [7]

    Oncol.209, DOI: 10.1016/j.radonc.2025

    Kacem, H.et al.Modification of the microstructure of the cern-clear-vhee beam at the picosecond scale modifies zfe morphogenesis but has no impact on hydrogen peroxide production.Radiother. Oncol.209, DOI: 10.1016/j.radonc.2025. 110942 (2025)

    work page doi:10.1016/j.radonc.2025 2025

  8. [8]

    & V ozenin, M.-C

    Kacem, H., Almeida, A., Cherbuin, N. & V ozenin, M.-C. Understanding the FLASH effect to unravel the potential of ultra-high dose rate irradiation.Int. J. Radiat. Biol.98, 506–516, DOI: 10.1080/09553002.2021.2004328 (2022)

    work page doi:10.1080/09553002.2021.2004328 2021

  9. [9]

    A., Prise, K

    Friedl, A. A., Prise, K. M., Butterworth, K. T., Montay-Gruel, P. & Favaudon, V . Radiobiology of the FLASH effect.Med. Phys.49, 1993–2013, DOI: 10.1002/mp.15184 (2022)

    work page doi:10.1002/mp.15184 1993

  10. [10]

    M., Long, K

    McGarrigle, J. M., Long, K. R. & Prezado, Y . The flash effect—an evaluation of preclinical studies of ultra-high dose rate radiotherapy.Front. Oncol.14, 1340190 (2024). 10/14

    2024

  11. [11]

    Borghini, A.et al.Flash ultra-high dose rates in radiotherapy: preclinical and radiobiological evidence.Int. J. Radiat. Biol. 98, 127–135, DOI: 10.1080/09553002.2022.2009143 (2022). PMID: 34913413, https://doi.org/10.1080/09553002.2022. 2009143

    work page doi:10.1080/09553002.2022.2009143 2022

  12. [12]

    Borghini, A.et al.Flash radiotherapy: Expectations, challenges, and current knowledge.Int. J. Mol. Sci.25, 2546, DOI: 10.3390/ijms25052546 (2024)

    work page doi:10.3390/ijms25052546 2024

  13. [13]

    Chow, J. C. L. & Ruda, H. E. Mechanisms of action in flash radiotherapy: A comprehensive review of physicochemical and biological processes on cancerous and normal cells.Cells13, 835, DOI: 10.3390/cells13100835 (2024)

    work page doi:10.3390/cells13100835 2024

  14. [14]

    & D’Orsi, B

    Rosini, G., Ciarrocchi, E. & D’Orsi, B. Mechanisms of the flash effect: Current insights and advances.Front. Cell Dev. Biol.13, 1575678, DOI: 10.3389/fcell.2025.1575678 (2025)

    work page doi:10.3389/fcell.2025.1575678 2025

  15. [15]

    D., Hammond, E

    Wilson, J. D., Hammond, E. M., Higgins, G. S. & Petersson, K. Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool’s Gold?Front. Oncol.9, 1563, DOI: 10.3389/fonc.2019.01563 (2020)

    work page doi:10.3389/fonc.2019.01563 2019

  16. [16]

    E.et al.Megavolt bremsstrahlung measurements from linear induction accelerators demonstrate possible use as a FLASH radiotherapy source to reduce acute toxicity.Sci

    Sampayan, S. E.et al.Megavolt bremsstrahlung measurements from linear induction accelerators demonstrate possible use as a FLASH radiotherapy source to reduce acute toxicity.Sci. Reports11, 17104, DOI: 10.1038/s41598-021-95807-9 (2021)

    work page doi:10.1038/s41598-021-95807-9 2021

  17. [17]

    Esplen, N., Mendonca, M. S. & Bazalova-Carter, M. Physics and biology of ultrahigh dose-rate (FLASH) radiotherapy: a topical review.Phys. Medicine & Biol.65, 23TR03, DOI: 10.1088/1361-6560/abaa28 (2020). 18.Bourhis, J.et al.Treatment of a first patient with flash-radiotherapy.Radiother. oncology139, 18–22 (2019)

    work page doi:10.1088/1361-6560/abaa28 2020

  18. [18]

    G.et al.Back to the Future: Very High-Energy Electrons (VHEEs) and Their Potential Application in Radiation Therapy.Cancers13, 4942, DOI: 10.3390/cancers13194942 (2021)

    Ronga, M. G.et al.Back to the Future: Very High-Energy Electrons (VHEEs) and Their Potential Application in Radiation Therapy.Cancers13, 4942, DOI: 10.3390/cancers13194942 (2021)

    work page doi:10.3390/cancers13194942 2021

  19. [19]

    & Di Martino, F

    Righi, S., Karaj, E., Felici, G. & Di Martino, F. Dosimetric characteristics of electron beams produced by two mobile accelerators, Novac7 and Liac, for intraoperative radiation therapy through Monte Carlo simulation.J. Appl. Clin. Med. Phys.14, 6–18, DOI: 10.1120/jacmp.v14i1.3678 (2013)

    work page doi:10.1120/jacmp.v14i1.3678 2013

  20. [20]

    Lempart, M.et al.Modifying a clinical linear accelerator for delivery of ultra-high dose rate irradiation.Radiother. Oncol. 139, 40–45, DOI: 10.1016/j.radonc.2019.01.031 (2019)

    work page doi:10.1016/j.radonc.2019.01.031 2019

  21. [21]

    Rahman, M.et al.Electron FLASH Delivery at Treatment Room Isocenter for Efficient Reversible Conversion of a Clinical LINAC.Int. J. Radiat. Oncol.110, 872–882, DOI: 10.1016/j.ijrobp.2021.01.011 (2021)

    work page doi:10.1016/j.ijrobp.2021.01.011 2021

  22. [22]

    Felici, G.et al.Transforming an IORT Linac Into a FLASH Research Machine: Procedure and Dosimetric Characterization. Front. Phys.8, 374, DOI: 10.3389/fphy.2020.00374 (2020). 24.Theriq company website. https://www.theryq-alcen.com/flash-radiotherapy-products/flashdeep/. Accessed: 02-26-2026. 25.Lumitron company website. https://www.lumitronxrays.com/. Acce...

    work page doi:10.3389/fphy.2020.00374 2020

  23. [23]

    & Schippers, M

    Farr, J., Grilj, V ., Malka, V ., Sudharsan, S. & Schippers, M. Ultra-high dose rate radiation production and delivery systems intended for FLASH.Med. Phys.49, 4875–4911, DOI: 10.1002/mp.15659 (2022)

    work page doi:10.1002/mp.15659 2022

  24. [24]

    DesRosiers, C., Moskvin, V ., Bielajew, A. F. & Papiez, L. 150-250 MeV electron beams in radiation therapy.Phys. Medicine Biol.45, 1781–1805, DOI: 10.1088/0031-9155/45/7/306 (2000)

    work page doi:10.1088/0031-9155/45/7/306 2000

  25. [25]

    Yeboah, C., Sandison, G. A. & Moskvin, V . Optimization of intensity-modulated very high energy (50–250 MeV) electron therapy.Phys. Medicine Biol.47, 1285–1301, DOI: 10.1088/0031-9155/47/8/305 (2002)

    work page doi:10.1088/0031-9155/47/8/305 2002

  26. [26]

    Oncol.119, 154–158, DOI: 10.1016/j.radonc.2016.01.017 (2016)

    Palma, B.et al.Assessment of the quality of very high-energy electron radiotherapy planning.Radiother. Oncol.119, 154–158, DOI: 10.1016/j.radonc.2016.01.017 (2016)

    work page doi:10.1016/j.radonc.2016.01.017 2016

  27. [27]

    Phys.11, DOI: 10.3389/fphy.2023.1185598 (2023)

    Muscato, A.et al.Treatment planning of intracranial lesions with vhee: comparing conventional and flash irradiation potential with state-of-the-art photon and proton radiotherapy.Front. Phys.11, DOI: 10.3389/fphy.2023.1185598 (2023)

    work page doi:10.3389/fphy.2023.1185598 2023

  28. [28]

    T.et al.Very high-energy electron therapy as light-particle alternative to transmission proton flash therapy – an evaluation of dosimetric performances.Radiother

    Böhlen, T. T.et al.Very high-energy electron therapy as light-particle alternative to transmission proton flash therapy – an evaluation of dosimetric performances.Radiother. Oncol.194, 110177, DOI: 10.1016/j.radonc.2024.110177 (2024)

    work page doi:10.1016/j.radonc.2024.110177 2024

  29. [29]

    Gesualdi, F.et al.Comparison of protons and very high-energy electrons transmission pencil-beam-scanning for flash radiotherapy.Phys. Radiat. Oncol. (PHRO)DOI: 10.1016/j.phro.2025.100860 (2025). Transmission proton and VHEE PBS treatment plan comparison with dose rate quantification relevant to FLASH radiotherapy

    work page doi:10.1016/j.phro.2025.100860 2025

  30. [30]

    Phys.42, 2615–2625, DOI: 10.1118/1.4918923 (2015)

    Bazalova-Carter, M.et al.Treatment planning for radiotherapy with very high-energy electron beams and comparison of VHEE and VMAT plans.Med. Phys.42, 2615–2625, DOI: 10.1118/1.4918923 (2015). 11/14

    work page doi:10.1118/1.4918923 2015

  31. [31]

    Medicine Biol.54, 3315–3328, DOI: 10.1088/0031-9155/54/11/003 (2009)

    Fuchs, T.et al.Treatment planning for laser-accelerated very-high energy electrons.Phys. Medicine Biol.54, 3315–3328, DOI: 10.1088/0031-9155/54/11/003 (2009)

    work page doi:10.1088/0031-9155/54/11/003 2009

  32. [32]

    Oncol.175, 210–221, DOI: 10.1016/j.radonc.2022.08.009 (2022)

    Rahman, M.et al.FLASH radiotherapy treatment planning and models for electron beams.Radiother. Oncol.175, 210–221, DOI: 10.1016/j.radonc.2022.08.009 (2022)

    work page doi:10.1016/j.radonc.2022.08.009 2022

  33. [33]

    Instruments Methods Phys

    Lagzda, A.et al.Influence of heterogeneous media on Very High Energy Electron (VHEE) dose penetration and a Monte Carlo-based comparison with existing radiotherapy modalities.Nucl. Instruments Methods Phys. Res. Sect. B: Beam Interactions with Mater. Atoms482, 70–81, DOI: 10.1016/j.nimb.2020.09.008 (2020)

    work page doi:10.1016/j.nimb.2020.09.008 2020

  34. [34]

    DesRosiers, C., Moskvin, V ., Cao, M., Joshi, C. J. & Langer, M. Laser-plasma generated very high energy electrons in radiation therapy of the prostate. 688109, DOI: 10.1117/12.761663 (San Jose, CA, 2008)

    work page doi:10.1117/12.761663 2008

  35. [35]

    G., Tantawi, S

    Maxim, P. G., Tantawi, S. G. & Loo, B. W. PHASER: A platform for clinical translation of FLASH cancer radiotherapy. Radiother. Oncol.139, 28–33, DOI: 10.1016/j.radonc.2019.05.005 (2019)

    work page doi:10.1016/j.radonc.2019.05.005 2019

  36. [36]

    Reports9, 10837, DOI: 10.1038/s41598-019-46630-w (2019)

    Kokurewicz, K.et al.Focused very high-energy electron beams as a novel radiotherapy modality for producing high-dose volumetric elements.Sci. Reports9, 10837, DOI: 10.1038/s41598-019-46630-w (2019)

    work page doi:10.1038/s41598-019-46630-w 2019

  37. [37]

    Esarey, E., Schroeder, C. B. & Leemans, W. P. Physics of laser-driven plasma-based electron accelerators.Rev. Mod. Phys. 81, 1229–1285, DOI: 10.1103/RevModPhys.81.1229 (2009)

    work page doi:10.1103/revmodphys.81.1229 2009

  38. [38]

    Gonsalves, A.et al.Petawatt Laser Guiding and Electron Beam Acceleration to 8 GeV in a Laser-Heated Capillary Discharge Waveguide.Phys. Rev. Lett.122, 084801, DOI: 10.1103/PhysRevLett.122.084801 (2019)

    work page doi:10.1103/physrevlett.122.084801 2019

  39. [39]

    N.et al.Petawatt and exawatt class lasers worldwide.High Power Laser Sci

    Danson, C. N.et al.Petawatt and exawatt class lasers worldwide.High Power Laser Sci. Eng.7, e54, DOI: 10.1017/hpl. 2019.36 (2019)

    work page doi:10.1017/hpl 2019

  40. [40]

    A.et al.Overview and specifications of laser and target areas at the Intense Laser Irradiation Laboratory.High Power Laser Sci

    Gizzi, L. A.et al.Overview and specifications of laser and target areas at the Intense Laser Irradiation Laboratory.High Power Laser Sci. Eng.9, e10, DOI: 10.1017/hpl.2020.47 (2021)

    work page doi:10.1017/hpl.2020.47 2020

  41. [41]

    Decoding Sources of Energy Variability in a Laser-Plasma Accelerator

    Maier, A. R.et al.Decoding Sources of Energy Variability in a Laser-Plasma Accelerator.Phys. Rev. X10, 031039, DOI: 10.1103/PhysRevX.10.031039 (2020)

    work page doi:10.1103/physrevx.10.031039 2020

  42. [42]

    (ed.)Laser-Driven Particle Acceleration Towards Radiobiology and Medicine

    Giulietti, A. (ed.)Laser-Driven Particle Acceleration Towards Radiobiology and Medicine. Biological and Medical Physics, Biomedical Engineering (Springer International Publishing, Cham, 2016)

    2016

  43. [43]

    Phys.V olume 12 - 2024, DOI: 10.3389/fphy.2024.1496272 (2025)

    Li, H.et al.Design of a 100-mev compact vhee beam line in tsinghua university.Front. Phys.V olume 12 - 2024, DOI: 10.3389/fphy.2024.1496272 (2025)

    work page doi:10.3389/fphy.2024.1496272 2024

  44. [44]

    Guo, Z.et al.Preclinical tumor control with a laser-accelerated high-energy electron radiotherapy prototype.Nat. Commun. 16, 1895, DOI: 10.1038/s41467-025-57122-z (2025)

    work page doi:10.1038/s41467-025-57122-z 2025

  45. [45]

    Reports10, 17307, DOI: 10.1038/s41598-020-74256-w (2020)

    Labate, L.et al.Toward an effective use of laser-driven very high energy electrons for radiotherapy: Feasibility assessment of multi-field and intensity modulation irradiation schemes.Sci. Reports10, 17307, DOI: 10.1038/s41598-020-74256-w (2020)

    work page doi:10.1038/s41598-020-74256-w 2020

  46. [46]

    Reports11, 5844, DOI: 10.1038/s41598-021-85451-8 (2021)

    Svendsen, K.et al.A focused very high energy electron beam for fractionated stereotactic radiotherapy.Sci. Reports11, 5844, DOI: 10.1038/s41598-021-85451-8 (2021)

    work page doi:10.1038/s41598-021-85451-8 2021

  47. [47]

    Oncol.11, 777852, DOI: 10.3389/fonc.2021.777852 (2021)

    Sarti, A.et al.Deep Seated Tumour Treatments With Electrons of High Energy Delivered at FLASH Rates: The Example of Prostate Cancer.Front. Oncol.11, 777852, DOI: 10.3389/fonc.2021.777852 (2021)

    work page doi:10.3389/fonc.2021.777852 2021

  48. [48]

    & Wernicke, A

    Mann, J., Ramakrishna, R., Magge, R. & Wernicke, A. G. Advances in Radiotherapy for Glioblastoma.Front. Neurol.8, 748, DOI: 10.3389/fneur.2017.00748 (2018)

    work page doi:10.3389/fneur.2017.00748 2017

  49. [49]

    and Laversanne, Mathieu and Soerjomataram, Isabelle and Jemal, Ahmedin and Bray, Freddie , title =

    Sung, H.et al.Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA: A Cancer J. for Clin.71, 209–249, DOI: https://doi.org/10.3322/caac.21660 (2021)

    work page doi:10.3322/caac.21660 2020

  50. [50]

    N.et al.The 2016 world health organization classification of tumors of the central nervous system: a summary

    Louis, D. N.et al.The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta neuropathologica131, 803–820 (2016)

    2016

  51. [51]

    neuro-oncology107, 207–212 (2012)

    Koshy, M.et al.Improved survival time trends for glioblastoma using the seer 17 population-based registries.J. neuro-oncology107, 207–212 (2012)

    2012

  52. [52]

    journal medicine 352, 987–996 (2005)

    Stupp, R.et al.Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.New Engl. journal medicine 352, 987–996 (2005). 56.Barani, I. J. & Larson, D. A. Radiation therapy of glioblastoma.Curr. understanding treatment gliomas49–73 (2015). 57.DeNunzio, N. J. & Yock, T. I. Modern radiotherapy for pediatric brain tumors.Cancers12, 1533 (2020). 12/14

    2005

  53. [53]

    M., Rapp, S

    Butler, J. M., Rapp, S. R. & Shaw, E. G. Managing the cognitive effects of brain tumor radiation therapy.Curr. treatment options oncology7, 517–523 (2006)

    2006

  54. [54]

    Cancer Res.27, 775–784 (2021)

    Montay-Gruel, P.et al.Hypofractionated flash-rt as an effective treatment against glioblastoma that reduces neurocognitive side effects in mice.Clin. Cancer Res.27, 775–784 (2021)

    2021

  55. [55]

    Oncol.124, 365–369 (2017)

    Montay-Gruel, P.et al.Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with dose rates above 100 gy/s.Radiother. Oncol.124, 365–369 (2017)

    2017

  56. [56]

    Alaghband, Y .et al.Neuroprotection of radiosensitive juvenile mice by ultra-high dose rate flash irradiation.Cancers12, 1671 (2020)

    2020

  57. [57]

    B.et al.Demonstration of a Narrow Energy Spread, ~0.5 GeV Electron Beam from a Two-Stage Laser Wakefield Accelerator.Phys

    Pollock, B. B.et al.Demonstration of a Narrow Energy Spread, ~0.5 GeV Electron Beam from a Two-Stage Laser Wakefield Accelerator.Phys. Rev. Lett.107, 045001, DOI: 10.1103/PhysRevLett.107.045001 (2011)

    work page doi:10.1103/physrevlett.107.045001 2011

  58. [58]

    Buck, A.et al.Shock-Front Injector for High-Quality Laser-Plasma Acceleration.Phys. Rev. Lett.110, 185006, DOI: 10.1103/PhysRevLett.110.185006 (2013)

    work page doi:10.1103/physrevlett.110.185006 2013

  59. [59]

    J.et al.Tunable laser plasma accelerator based on longitudinal density tailoring.Nat

    Gonsalves, A. J.et al.Tunable laser plasma accelerator based on longitudinal density tailoring.Nat. Phys.7, 862–866, DOI: 10.1038/nphys2071 (2011)

    work page doi:10.1038/nphys2071 2011

  60. [60]

    Reports5, 16310, DOI: 10.1038/ srep16310 (2015)

    Thaury, C.et al.Shock assisted ionization injection in laser-plasma accelerators.Sci. Reports5, 16310, DOI: 10.1038/ srep16310 (2015)

    2015

  61. [61]

    Tomassini, P.et al.High quality electron bunches for a multistage GeV accelerator with resonant multipulse ionization injection.Phys. Rev. Accel. Beams22, 111302, DOI: 10.1103/PhysRevAccelBeams.22.111302 (2019)

    work page doi:10.1103/physrevaccelbeams.22.111302 2019

  62. [62]

    & Moskvin, V

    Papiez, L., DesRosiers, C. & Moskvin, V . Very High Energy Electrons (50 – 250 MeV) and Radiation Therapy.Technol. Cancer Res. & Treat.1, 105–110, DOI: 10.1177/153303460200100202 (2002)

    work page doi:10.1177/153303460200100202 2002

  63. [63]

    M.et al.Clinical electron-beam dosimetry: Report of AAPM Radiation Therapy Committee Task Group No

    Khan, F. M.et al.Clinical electron-beam dosimetry: Report of AAPM Radiation Therapy Committee Task Group No. 25. Med. Phys.18, 73–109, DOI: 10.1118/1.596695 (1991)

    work page doi:10.1118/1.596695 1991

  64. [64]

    T.et al.Normal Tissue Sparing by FLASH as a Function of Single-Fraction Dose: A Quantitative Analysis.Int

    Böhlen, T. T.et al.Normal Tissue Sparing by FLASH as a Function of Single-Fraction Dose: A Quantitative Analysis.Int. J. Radiat. Oncol.114, 1032–1044, DOI: 10.1016/j.ijrobp.2022.05.038 (2022)

    work page doi:10.1016/j.ijrobp.2022.05.038 2022

  65. [65]

    & Krus, M

    Gajdos, P. & Krus, M. Ultrashort electron beam isochronous, achromatic transport line design. In Bulanov, S. S., Schreiber, J. & Schroeder, C. B. (eds.)Laser Acceleration of Electrons, Protons, and Ions VI, vol. 11779, 117790G, DOI: 10.1117/12.2589208. International Society for Optics and Photonics (SPIE, 2021)

    work page doi:10.1117/12.2589208 2021

  66. [66]

    at Extrem.9, 014001, DOI: 10.1063/5.0161687 (2023)

    Aniculaesei, C.et al.The acceleration of a high-charge electron bunch to 10 GeV in a 10-cm nanoparticle-assisted wakefield accelerator.Matter Radiat. at Extrem.9, 014001, DOI: 10.1063/5.0161687 (2023)

    work page doi:10.1063/5.0161687 2023

  67. [67]

    Rovige, L.et al.Demonstration of stable long-term operation of a kilohertz laser-plasma accelerator.Phys. Rev. Accel. Beams23, 093401, DOI: 10.1103/PhysRevAccelBeams.23.093401 (2020)

    work page doi:10.1103/physrevaccelbeams.23.093401 2020

  68. [68]

    Tuscany Health Ecosystem (THE) Spoke 1, Advanced Radiotherapies and Diagnostics in Oncology

    Lehe, R., Kirchen, M., Andriyash, I. A., Godfrey, B. B. & Vay, J.-L. A spectral, quasi-cylindrical and dispersion-free particle-in-cell algorithm.Comput. Phys. Commun.203, 66–82, DOI: https://doi.org/10.1016/j.cpc.2016.02.007 (2016). For data citations of datasets uploaded to e.g.figshare, please use the howpublished option in the bib entry to specify the...

    work page doi:10.1016/j.cpc.2016.02.007 2016